An innovative combination therapy can force malignant breast cancer cells to turn into fat cells. This can be used to prevent the formation of metastases in mice, as researchers recently reported in the journal Cancer Cell.
Tumor cells can adapt dynamically to changing conditions thanks to their ability to reactivate a cellular process that is central to embryonic development. This allows the cells to alter their molecular properties and to acquire new capabilities.
As a result, resident cells can adopt the properties of other cell types and break away from their cell cluster. Once mobile, the cells migrate via the bloodstream to other regions of the body, where they undergo a further conversion before taking root and forming new tissue structures.
In the embryo, this epithelial-mesenchymal transition (EMT) is instrumental to the development of organs. Tumor cells, however, exploit the process in order to leave the primary tumor so that they can spread around the body and form metastases in distant organs.
In experiments on mice, they have succeeded in using a combination of two active substances to convert breast cancer cells, which divide quickly and form metastases, into fat cells that can no longer divide and can barely be differentiated from normal fat cells. This stops the tumor from invading the neighboring tissue and blood vessels, and no further metastases can form.
This novel differentiation therapy is based on a combination of two drugs: Rosiglitazone, which is widely used to treat patients with diabetes, and Trametinib, which inhibits the growth and spread of cancer cells.
"In future, this innovative therapeutic approach could be used in combination with conventional chemotherapy to suppress both primary tumor growth and the formation of deadly metastases," says the author Furthermore, the research findings show that malignant cancer cells - like stem cells - exhibit a high degree of cell plasticity, which can be exploited for therapeutic purposes.
https://www.cell.com/cancer-cell/fulltext/S1535-6108(18)30573-7
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fgain-fat-lose&filter=224
Latest News
Many psychiatric disorders arise from common genes
Mitochondrial DNA stress signalling protects the nuclear genome
Artificial intelligence to detect cancer metastasis in the entire body
Why doesn't deep-brain stimulation work for everyone?
A vaccine against chronic inflammatory diseases
Other Top Stories
Researchers create artificial protein to control assembly of buckyballs
Mapping the circuit of our internal clock
Tension-sensitive molecule helps cells divide chromosomes accurately
A gene signature associated with dilated cardiomyopathy
Key factor in mitochondrial calcium uptake and bioenergetics identified
Protocols
Dual-Angle Protocol for Doppler Optical Coherence Tomography to Improve Retinal Blood Flow Measur…
Detection of protein SUMOylation in vivo
In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induce…
Determination of SUMOylation sites
miR-Selection 3'UTR Target Selection Kit
Publications
Flagellin-elicited adaptive immunity suppresses flagellated microbiota and vaccinates against chr…
IgGs from patients with amyotrophic lateral sclerosis and diabetes target CaVα2δ1 subunits impair…
Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues
Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a M…
Stem-cell-ubiquitous genes spatiotemporally coordinate division through regulation of stem-cell-s…
Presentations
Hypoxia Inducible Factor - 1 (HIF-1)
Intracellular Protein Degradation
Pathophysiology of Type 1 Diabetes
Plant Viruses
Regulation by changes in chromatin structure
Posters
AACC-2018-Infectious Disease
AACC-2018-Mass Spectrometry Applications
AACC-2018-Lipids/Lipoproteins
AACC-2018-Management
AACC-2018-Immunology-abstracts